Kura Oncology (KURA) Cash from Operations (2010 - 2026)

Kura Oncology (KURA) has 17 years of Cash from Operations data on file, last reported at 85854000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 19.36% year-over-year to 85854000.0 in Q1 2026; TTM through Mar 2026 was 77985000.0, a 170.11% decrease from a year earlier, with the FY2025 full-year figure at 64058000.0, down 147.69% from the prior year.
• Cash from Operations for Q1 2026 stood at 85854000.0, down from 117273000.0 in the prior quarter.
• Over the last five years, Cash from Operations for KURA reached as high as 269131000.0 in Q4 2024 and fell as low as 85854000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 14734176.47 across 5 years, with a median of 32181000.0 in 2022.
• Across the five-year window, Cash from Operations surged 884.46% in 2024 and sank 85.61% in 2025, its largest moves.
• Year by year, Cash from Operations stood at 26530000.0 in 2022, then declined by 29.32% to 34308000.0 in 2023, then jumped by 884.46% to 269131000.0 in 2024, then sank by 56.43% to 117273000.0 in 2025, then sank by 173.21% to 85854000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 85854000.0 in Q1 2026, 117273000.0 in Q4 2025, and 80627000.0 in Q3 2025.